CONMED Q2 FY26 adjusted EPS rises 20% to $1.38; net sales increase 0.3% to $343.5 million - CNMD News | RalliesCONMED Q2 FY26 adjusted EPS rises 20% to $1.38; net sales increase 0.3% to $343.5 million
C
CNMD• Q2 results
- CONMED posted Q2 2026 net sales of $343.5 million, up 0.3% year over year.
- GAAP diluted EPS rose 11.6% to $0.77; GAAP net income climbed to $23.07 million from $21.42 million.
- Non-GAAP adjusted diluted EPS increased 20% to $1.38, including a $0.21 benefit from IEEPA tariff refunds.
Updated guidance and recent developments
- Updated FY 2026 net sales guidance was set at $1.36 billion-$1.37 billion; non-GAAP adjusted diluted EPS forecast was lifted to $4.48-$4.60.
- The company named John E. Gallagher CFO effective July 15.
- AirSeal Robotic Solution was cleared for Intuitive da Vinci 5 8 mm hex cannulas.
•
